National Database of Bone Metastases

Launched by ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI DINO AMADORI IRST S.R.L. IRCCS · Apr 11, 2024

Keywords

ClinConnect Summary

The National Database of Bone Metastases (BDMO) is a research study happening in Italy that aims to collect important information about patients who have bone metastases, which means cancer that has spread to the bones from other parts of the body. This study is observational, meaning researchers will gather data from patients as they receive care, without changing their treatment. Anyone aged 18 or older who has been diagnosed with bone metastases from a solid tumor, confirmed by medical imaging or tissue testing, can potentially join the study.

Participants will be asked to provide their consent to take part in the study, and they will help researchers gather valuable information through a specialized online system. This study is currently recruiting new patients, and it includes individuals of all genders. By participating, patients will contribute to a better understanding of bone metastases, which can help improve future care for others facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Radiological and/or histological diagnosis of bone metastasis from histologically established solid tumor
• • Males or females aged \>= 18 years
• • Informed consent
• Exclusion Criteria:
• • Not applicable